Patents
View all stories with this category.
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
OpinionPushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
-
OpinionHas Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
-
Business‘No deal’ Brexit guidance fails to reassure UK chemical industry
UK government issues guidance on chemical regulation and patent law if the UK leaves the EU without agreement
-
SponsoredThe dark side of chemical patents
Unloved, ignored and misunderstood but could all that change?
-
SponsoredA guide to searching and using Markush structures
Chemical patents are often very long and difficult to read. Markush searching can enable you to easily categorise and filter the information you need, giving you the insights that a paper sometimes cannot.
-
-
BusinessPharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
BusinessFederal court quashes Allergan eye drop patents
Ruling negates company’s deal with Mohawk tribe to avoid patent board review
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
- Previous page
- #*#*PageLabel*#*#1
- #*#*PageLabel*#*#2
- #*#*PageLabel*#*#3
- #*#*PageLabel*#*#4
- #*#*PageLabel*#*#5
- #*#*PageLabel*#*#6
- Next page
